Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Health Canada approves Velkury to treat pneumonia associated with COVID-19. -Gilead Sciences

Written by | 29 Jul 2020 | COVID-19

Health Canada has approved, with conditions, remdesivir (Velkury) from Gilead Sciences to treat COVID-19 patients. Remdesivir is used to treat those with pneumonia who need extra oxygen to breathe. It is the first drug the national health agency has approved to treat the coronavirus. The approval comes after an expedited six-week review of the medication, which is already being used in the U.S., Japan, and Australia.

Remdesivir is authorized for use in adults and adolescents (aged 12 years and older with a body weight of at least 40 kg). Remdesivir is administered intravenously and will be used only in healthcare facilities where patients can be closely monitored..

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.